Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1940 Jan;19(1):123–127. doi: 10.1172/JCI101106

THE OCCURRENCE OF METHEMOGLOBINEMIA DURING SULFANILAMIDE THERAPY

Charles L Fox Jr 1,2,1, James E Cline 1,2
PMCID: PMC434948  PMID: 16694720

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chesley L. C. CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT. J Clin Invest. 1938 Jul;17(4):445–447. doi: 10.1172/JCI100971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Harris J. S., Michel H. O. THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY. J Clin Invest. 1939 Sep;18(5):507–519. doi: 10.1172/JCI101064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Wendel W. B. THE CONTROL OF METHEMOGLOBINEMIA WITH METHYLENE BLUE. J Clin Invest. 1939 Mar;18(2):179–185. doi: 10.1172/JCI101033. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES